B
BZAM Ltd
CNSX:BZAM
BZAM Ltd
CNSX:BZAM
Price:
0.025
CAD
Market Cap:
CA$4.5m
Relative Value
There is not enough data to reliably calculate the relative value of BZAM.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BZAM
Relative Value
Base Case
Not Available
Multiples Across Competitors
BZAM Competitors Multiples
BZAM Ltd Competitors
BZAM Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
B
|
BZAM Ltd
CNSX:BZAM
|
4.5m CAD | 0.1 | -0 | -0.3 | -0.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
985.1B USD | 16.6 | 53.6 | 36 | 38.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
554.2B USD | 5.9 | 20.7 | 14.4 | 17.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
283.2B CHF | 4.6 | 30 | 12.7 | 14.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.3B GBP | 5.1 | 31.5 | 15 | 22 | |
| CH |
|
Novartis AG
SIX:NOVN
|
224.7B CHF | 5.1 | 20 | 12.6 | 16.3 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
281.3B USD | 4.4 | 14.8 | 10.5 | 12.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.7T DKK | 5.2 | 16 | 11.1 | 12.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
150.9B USD | 2.4 | 15.4 | 7.8 | 10.6 | |
| FR |
|
Sanofi SA
PAR:SAN
|
97.3B EUR | 1.7 | 8.2 | 7.6 | 7.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
